{"entity":{"type":"insider","cik":"0001352908","url":"/insider/0001352908","json_url":"/insider/0001352908.json","name":"Hayden Michael R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":12,"first":"2017-08-14","last":"2026-08-24","span_basis":"filed_date"},"name_variants":[{"name":"Hayden Michael R","source":"filing","n_filings":12,"first_seen":"2017-08-14","last_seen":"2026-08-24"}],"transactions":[{"id":9300669,"accession":"0001628280-26-058684","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-058684","line_url":"/filing/0001628280-26-058684#line-1","is_derivative":false,"issuer_cik":"0001703057","issuer_name":"AbCellera Biologics Inc.","issuer_ticker":"ABCL","issuer_name_source":null,"issuer_url":"/issuer/0001703057","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":53613.0,"shares_display":"53,613","price_per_share":10.64,"price_display":"10.64","price_state":"stated","total_value":570442.32,"total_display":"570,442.32","total_whole":"570,442","shares_owned_after":1373397.0,"shares_owned_after_display":"1,373,397","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-24","filed_date":"2026-08-24","scope":"insider"},{"id":9293720,"accession":"0001628280-26-057007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-057007","line_url":"/filing/0001628280-26-057007#line-1","is_derivative":false,"issuer_cik":"0001352908","issuer_name":"AbCellera Biologics Inc.","issuer_ticker":"ABCL","issuer_name_source":null,"issuer_url":"/issuer/0001352908","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":46387.0,"shares_display":"46,387","price_per_share":10.37,"price_display":"10.37","price_state":"stated","total_value":481033.19,"total_display":"481,033.19","total_whole":"481,033","shares_owned_after":1319784.0,"shares_owned_after_display":"1,319,784","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-12","filed_date":"2026-08-14","scope":"insider"},{"id":5954691,"accession":"0000874015-26-000254","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-26-000254","line_url":"/filing/0000874015-26-000254#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":51.6,"price_display":"51.60","price_state":"stated","total_value":258000.0,"total_display":"258,000.00","total_whole":"258,000","shares_owned_after":24000.0,"shares_owned_after_display":"24,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-31","filed_date":"2026-07-31","scope":"insider"},{"id":5954688,"accession":"0000874015-26-000254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-26-000254","line_url":"/filing/0000874015-26-000254#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":53.38,"price_display":"53.38","price_state":"stated","total_value":800700.0,"total_display":"800,700.00","total_whole":"800,700","shares_owned_after":19000.0,"shares_owned_after_display":"19,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-30","filed_date":"2026-07-31","scope":"insider"},{"id":5189113,"accession":"0000874015-25-000125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-25-000125","line_url":"/filing/0000874015-25-000125#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":31.86,"price_display":"31.86","price_state":"stated","total_value":477900.0,"total_display":"477,900.00","total_whole":"477,900","shares_owned_after":50219.0,"shares_owned_after_display":"50,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-01","filed_date":"2025-05-02","scope":"insider"},{"id":2884080,"accession":"0000874015-24-000243","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-24-000243","line_url":"/filing/0000874015-24-000243","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":36.21575,"price_display":"36.22","price_state":"stated","total_value":181078.75,"total_display":"181,078.75","total_whole":"181,079","shares_owned_after":35219.0,"shares_owned_after_display":"35,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-23","filed_date":"2024-12-26","scope":"insider","n_lines":2},{"id":7936595,"accession":"0001703057-23-000032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001703057-23-000032","line_url":"/filing/0001703057-23-000032#line-1","is_derivative":false,"issuer_cik":"0001352908","issuer_name":"AbCellera Biologics Inc.","issuer_ticker":"ABCL","issuer_name_source":null,"issuer_url":"/issuer/0001352908","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":4.91,"price_display":"4.91","price_state":"stated","total_value":98200.0,"total_display":"98,200.00","total_whole":"98,200","shares_owned_after":1323397.0,"shares_owned_after_display":"1,323,397","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-22","filed_date":"2023-09-26","scope":"insider"},{"id":7823061,"accession":"0001703057-23-000024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001703057-23-000024","line_url":"/filing/0001703057-23-000024#line-1","is_derivative":false,"issuer_cik":"0001352908","issuer_name":"AbCellera Biologics Inc.","issuer_ticker":"ABCL","issuer_name_source":null,"issuer_url":"/issuer/0001352908","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":177000.0,"total_display":"177,000.00","total_whole":"177,000","shares_owned_after":1303397.0,"shares_owned_after_display":"1,303,397","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-08","filed_date":"2023-08-09","scope":"insider"},{"id":7888490,"accession":"0000950170-23-010969","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-23-010969","line_url":"/filing/0000950170-23-010969#line-4","is_derivative":false,"issuer_cik":"0001352908","issuer_name":"89bio, Inc.","issuer_ticker":"ETNB","issuer_name_source":null,"issuer_url":"/issuer/0001352908","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":61538.0,"shares_display":"61,538","price_per_share":16.15,"price_display":"16.15","price_state":"stated","total_value":993838.7,"total_display":"993,838.70","total_whole":"993,839","shares_owned_after":61538.0,"shares_owned_after_display":"61,538","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-28","filed_date":"2023-03-30","scope":"insider"},{"id":7888485,"accession":"0000950170-23-010969","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-23-010969","line_url":"/filing/0000950170-23-010969#line-3","is_derivative":false,"issuer_cik":"0001352908","issuer_name":"89bio, Inc.","issuer_ticker":"ETNB","issuer_name_source":null,"issuer_url":"/issuer/0001352908","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.67,"price_display":"2.67","price_state":"stated","total_value":26700.0,"total_display":"26,700.00","total_whole":"26,700","shares_owned_after":103978.0,"shares_owned_after_display":"103,978","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-25","filed_date":"2023-03-30","scope":"insider"},{"id":7888481,"accession":"0000950170-23-010969","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-010969","line_url":"/filing/0000950170-23-010969#line-2","is_derivative":false,"issuer_cik":"0001352908","issuer_name":"89bio, Inc.","issuer_ticker":"ETNB","issuer_name_source":null,"issuer_url":"/issuer/0001352908","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.475,"price_display":"3.48","price_state":"stated","total_value":34750.0,"total_display":"34,750.00","total_whole":"34,750","shares_owned_after":93978.0,"shares_owned_after_display":"93,978","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-07","filed_date":"2023-03-30","scope":"insider"},{"id":7888472,"accession":"0000950170-23-010969","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-010969","line_url":"/filing/0000950170-23-010969#line-1","is_derivative":false,"issuer_cik":"0001352908","issuer_name":"89bio, Inc.","issuer_ticker":"ETNB","issuer_name_source":null,"issuer_url":"/issuer/0001352908","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6250.0,"shares_display":"6,250","price_per_share":3.62,"price_display":"3.62","price_state":"stated","total_value":22625.0,"total_display":"22,625.00","total_whole":"22,625","shares_owned_after":83978.0,"shares_owned_after_display":"83,978","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-30","filed_date":"2023-03-30","scope":"insider"},{"id":4508983,"accession":"0000899243-21-025366","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-025366","line_url":"/filing/0000899243-21-025366#line-1","is_derivative":false,"issuer_cik":"0001352908","issuer_name":"AbCellera Biologics Inc.","issuer_ticker":"ABCL","issuer_name_source":null,"issuer_url":"/issuer/0001352908","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":25.5,"price_display":"25.50","price_state":"stated","total_value":2550000.0,"total_display":"2,550,000.00","total_whole":"2,550,000","shares_owned_after":1003397.0,"shares_owned_after_display":"1,003,397","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-22","filed_date":"2021-06-22","scope":"insider"},{"id":3167942,"accession":"0000899243-20-034340","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-034340","line_url":"/filing/0000899243-20-034340#line-3","is_derivative":false,"issuer_cik":"0001352908","issuer_name":"AbCellera Biologics Inc.","issuer_ticker":"ABCL","issuer_name_source":null,"issuer_url":"/issuer/0001352908","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":73665.0,"shares_display":"73,665","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":1473300.0,"total_display":"1,473,300.00","total_whole":"1,473,300","shares_owned_after":118245.0,"shares_owned_after_display":"118,245","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-17","scope":"insider"},{"id":7831324,"accession":"0000899243-19-027220","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-027220","line_url":"/filing/0000899243-19-027220#line-1","is_derivative":false,"issuer_cik":"0001352908","issuer_name":"89bio, Inc.","issuer_ticker":"ETNB","issuer_name_source":null,"issuer_url":"/issuer/0001352908","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18750.0,"shares_display":"18,750","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":18750.0,"shares_owned_after_display":"18,750","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-11","filed_date":"2019-11-13","scope":"insider"},{"id":4897754,"accession":"0001171843-17-005068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-17-005068","line_url":"/filing/0001171843-17-005068#line-1","is_derivative":false,"issuer_cik":"0001352908","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001352908","owner_cik":"0001352908","owner_name":"Hayden Michael R","owner_display_name":"Hayden Michael R","owner_url":"/insider/0001352908","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.7498,"price_display":"2.75","price_state":"stated","total_value":41247.0,"total_display":"41,247.00","total_whole":"41,247","shares_owned_after":161187.0,"shares_owned_after_display":"161,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-14","filed_date":"2017-08-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":16,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001703057","name":"AbCellera Biologics Inc.","url":"/issuer/0001703057","role":"Director","n_filings":6,"first_seen":"2020-12-17","last_seen":"2026-08-24"},{"type":"issuer","type_label":"ISSUER","cik":"0000874015","name":"IONIS PHARMACEUTICALS INC","url":"/issuer/0000874015","role":"Director","n_filings":3,"first_seen":"2024-12-26","last_seen":"2026-07-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001785173","name":"89bio, Inc.","url":"/issuer/0001785173","role":"Director","n_filings":2,"first_seen":"2019-11-13","last_seen":"2023-03-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001582313","name":"Xenon Pharmaceuticals Inc.","url":"/issuer/0001582313","role":"Director","n_filings":1,"first_seen":"2017-08-14","last_seen":"2017-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001352908","retrieved_at":"2026-08-26T11:51:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}